| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Consulting and advisory fees | 67,200 | |||
| Related party consulting fees | 74,000 | |||
| General and administrative expenses | 24,912 | |||
| Professional fees | 83,997 | |||
| Research and development expense | 53,966 | |||
| Total operating expenses | 304,075 | |||
| Loss from operations | -304,075 | |||
| Amortization of debt discount | 44,031 | |||
| Interest expense | 44,783 | |||
| Gain on extinguishment of debt | 2,743,546 | |||
| Total other income (expense) | 2,654,732 | |||
| Net income (loss) before income tax expense | 2,350,657 | |||
| Income tax expense | 124,585 | |||
| Net income (loss) | 2,226,072 | |||
| Less net loss attributable to noncontrolling interest | 0 | |||
| Net income (loss) attributable to common stockholders | 2,226,072 | |||
| Basic and diluted earnings per share on net income (loss) basic | 0 | |||
| Basic and diluted earnings per share on net income (loss) diluted | 0 | |||
| Weighted average number of common shares outstanding basic | 716,715,546 | |||
| Weighted average number of common shares outstanding diluted | 2,367,087,385 | |||
XERIANT, INC. (XERI)
XERIANT, INC. (XERI)